THE SUCCESSFUL EXPERIENCE OF ANTIVIRAL THERAPY FOR HEPATITIS C IN PATIENTS WITH HEPATOCELLULAR CARCINOMA IN THE EARLY POSTOPERATIVE PERIOD
- Authors: Poluektova VB.1, Czhao A.V.2, Konstantinova M.M.2, Davydenko P.I.2, Shevchenko T.V.2, Filippova E.M.2, Volchkova E.V.1
-
Affiliations:
- State Budgetary Educational Institution of Higher Professional Education “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health care and Social Development
- Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
- Issue: Vol 17, No 5 (2012)
- Pages: 57-61
- Section: Articles
- URL: https://journals.rcsi.science/1560-9529/article/view/40746
- DOI: https://doi.org/10.17816/EID40746
- ID: 40746
Cite item
Full Text
Abstract
Full Text
##article.viewOnOriginalSite##About the authors
V B. Poluektova
State Budgetary Educational Institution of Higher Professional Education “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health care and Social Development
Email: infection_mma@mail.ru
канд. мед. наук, доцент каф. инфекционных болезней Первого МГМУ им. И.М. Сеченова Moscow, Russian Federation
A. V. Czhao
Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
Email: vishnevskogo@ixv.ru
д-р мед. наук, проф., зам. директора по научной работе института хирургии им. А.В. Вишневского Moscow, Russian Federation
M. M. Konstantinova
Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
Email: vishnevskogo@ixv.ru
д-р мед. наук, проф., зам. директора по лечебной работе института хирургии им. А.В.Вишневского Moscow, Russian Federation
P. I. Davydenko
Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
Email: vishnevskogo@ixv.ru
канд. мед. наук, мл. науч. отр. отдела лучевых методов диагностики и лечения института хирургии им. А.В. Вишневского Moscow, Russian Federation
T. V. Shevchenko
Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
Email: vishnevskogo@ixv.ru
канд. мед. наук, ст. науч. сотр., отд-ния абдоминальной хирургии институт хирургии им. А.В. Вишневского Moscow, Russian Federation
E. M. Filippova
Federal State Budgetary Institution “Vishnevsky Institute of Surgery” of the Ministry of Healthcare and Social Development of the Russian Federation
Email: vishnevskogo@ixv.ru
врач-патологоанатом, зав. патологической анатомией, институт хирургии им. А.В. Вишневского Moscow, Russian Federation
E. V. Volchkova
State Budgetary Educational Institution of Higher Professional Education “I.M. Sechenov First Moscow State Medical University” of the Ministry of Health care and Social Development
Email: infection_mma@mail.ru
д-р мед наук, проф., зав. каф. инфекционных болезней Первого МГМУ им. И.М. Сеченова Moscow, Russian Federation
References
- Абдурахманов Д.Т. Перспективы в лечении хронического вирусного гепатита C. Клин.гепатология, 2010, 3, 3-11.
- Craxi A. Клинические рекомендации ЕАSL ведение больных с инфекцией вызванной вирусом гепатита C. Best clinical practice. Рус. изд. 2011. 5. 13-37.
- Ghany M.G., Stader D.B., Thomas D.L., Seeff L.B. Diagnosis, management and treatment of hepatitis C: an update. Hepatology 2009: 49: 1335-1374.
- Жданов К., Лобзин Ю.В., Гусев Д.А., Козлов К.В. Вирусные гепатиты. - СПб.: Фолиант; 2012.
- Bacon Br. R., O'Grady J. G., Di Bisceglie A. M., Lake J. R. Clinical he-patology. Elsevier MOSBY; 2006.
- El-Serag H.B., Rudoiph R.L. Hepatocellular carcinoma: epidemiology and molecular cancirogenesis. Gastroenterology 2007; 132: 2557-2576.
- Marcellin P., Assellah T., Boyer N. Fibrosis and disease progression in hepatitis C. Hepatology 2002; 36 (Suppl 1): 47-56.
- Alberti A. Impact of sustained virological response on the long-term outcome of hepatitis C. Liver Int. 2011, 31 (Suppl. 1): 18-22.
- Kirk G.D., Lesi O.A., Mendy M. et al. The Gambia Liver Cancer Study: infection with hepatitis and Cand the riskof hepatocellularcarcinoma in West Africa. Hepatology 2004, 39: 211-219.
- Серов В.В., Апросина З.Г. Хронический вирусный гепатит. - М.: Медицина, 2002.
- Adinolfi L.E., Utili R., Andreana A. et al. Serum HCV RNA levels corralate with histological liver damage and concur with steatosis in progression of chronic hepatitis C. Dig. Dis. Sci, 2001; 46: 1677-1683.
- Rubbia-Brandt L., Quardi R., Abid K. et al. Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3. Hepatology, 2000, 33: 106-115.
- Cardoso A.C., Moucari R., Figueredo-Mendes C. et al. Impact peginterferon and ribaverin therapyon hepatocellular carcinoma: incidence and survival in hepatits C pacients with advanced fibrosis. Hepatology 2010; 52: 652-65.